{"prompt": "['STABILITY 2', 'Version 1.4', 'PRO19020231', 'February 2, 2021', 'OA', 'Osteoarthritis', 'OHRP', 'Office for Human Research Protections', 'OR', 'Odds Ratio', 'PASC', 'Publications and Ancillary Studies Committee', 'PC', 'Project Coordinator', 'PD', 'Protocol Deviation', 'PI', 'Principal Investigator', 'PRO', 'Patient Reported Outcome', 'PTOA', 'Post-Traumatic Osteoarthritis', 'QC', 'Quality Control', 'QCL', 'Quality Control Lead', 'QALYS', 'Quality Adjusted Life Years', 'QOL', 'Quality of Life', 'QT', 'Quadriceps Tendon', 'RC', 'Research Coordinator', 'ROM', 'Range of Motion', 'RRR', 'Relative Risk Ratio', 'SAE', 'Serious Adverse Event', 'SSL', 'Scramble Word Format', 'UP', 'Unanticipated Problem', '16']['STABILITY 2', 'Version 1.4', 'PRO19020231', 'February 2, 2021', 'PROTOCOL SUMMARY', 'Title:', 'STABILITY 2: ACL Reconstruction +/- Lateral Tenodesis with', 'Patellar VS. Quad Tendon', 'Pr\u00e9cis:', 'STABILITY 2 is a 21-site multicenter, international, randomized', 'clinical trial that will randomly assign 1236 individuals with an', 'anterior cruciate ligament (ACL) deficient knee who are at high', 'risk of re-injury to anatomic anterior cruciate ligament', 'reconstruction (ACLR) using bone patellar tendon bone (BPTB)', 'or quadriceps tendon (QT) autograft with or without a lateral', 'extra-articular tenodesis (LET).', 'Objectives:', 'Aim 1: Determine if graft type (QT, BPTB or HT) with or without', 'a LET affects the rate of ACL clinical failure at 2 years after', 'ACLR.', 'Aim 2: Determine if graft type (QT, BPTB or HT) with or without', 'a LET affects patient-reported symptoms, function & QOL,', 'performance-based measures of function and return-to-sports 2', 'years after ACLR.', 'Aim 3: Determine if graft type (QT, BPTB or HT) with or without', 'LET affects the rates of intervention-related donor site', 'morbidity, complications and adverse outcomes 2 years after', 'ACLR.', 'Aim 4: Determine if use of a particular graft type (QT, BTPT or', 'HT) with or without addition of LET is a more cost-effective', 'approach to ACLR.', 'Population:', 'The study population will consist of 1236 young, active', 'individuals from the United States, Canada and Europe. Eligible', 'patients will have an ACL deficient knee, be skeletally mature', 'but <25 years of age, and meet 2 of the following criteria:', 'participate in a competitive pivoting sport; have a pivot shift of', 'grade 2 or greater; have generalized ligamentous laxity', '(Beighton score of >4) and/or genu recurvatum >10 degrees.', 'Phase:', 'III', 'Number of Sites:', '21', 'Description of', 'All patients will undergo an anatomic ACLR using BTBP or QT', 'Intervention:', 'autograft with or without LET.', 'Study Duration:', '60 months', 'Subject Participation', '24 months', 'Duration:', 'Estimated Time to', '30 months', 'Complete Enrollment:', '17']['STABILITY 2', 'Version 1.4', 'PRO19020231', 'February 2, 2021', 'SCHEMATIC OF STUDY DESIGN', 'STABILITY 2: FLOWCHART', 'BASELINE', 'DAY OF SURGERY', 'INELIGIBLE', 'Standard of Care Activities', 'Standard of Care Activities', 'Clinical Exam', 'Examination under anesthesia', 'Proceed with pre-determined', 'ELIGIBLE', 'Imaging: X-Ray (MRI as applicable)', 'Diagnostic Arthroscopy', 'surgical procedure', 'Range of motion Measurements', 'Pivot App Assessment', 'Research Activities', 'RANDOMIZATION', 'Informed Consent', 'To graft type', 'Patient Reported Outcomes', 'To tenodesis allocation', 'Strength Testing', '(Research activity)', 'STANDARD ACL-R SURGERY', 'Using graft and tenodesis allocation', '(Standard of care activity)', 'STANDARD PHYSICAL THERAPY', '6 WEEK POST OP', '3 MONTHS POST OP', '6 MONTHS POST OP', '12 MONTHS POST OP', '24 MONTHS POST OP', 'Standard of Care Activities', 'Standard of Care Activities', 'Standard of Care Activities', 'Standard of Care Activities', 'Standard of Care Activities', 'Clinical post-operative examination', 'Clinical post-operative examination', 'Clinical post-operative examination', 'Clinical post-operative examination', 'Clinical post-operative examination', 'Range of Motion measurements', 'Range of Motion measurements', 'Range of Motion measurements', 'Range of Motion measurements', 'Range of Motion measurements', 'Donor site morbidity assessment', 'Donor site morbidity assessment', 'Donor site morbidity assessment', 'Donor site morbidity assessment', 'Donor site morbidity assessment', 'PIVOT shift manual assessment', 'PIVOT shift manual assessment', 'PIVOT shift manual assessment', 'PIVOT shift manual assessment', 'Research Activities', 'Patient Reported Outcomes', 'Research Activities', 'Research Activities', 'Research Activities', 'Research Activities', 'Patient Reported Outcomes', 'Patient Reported Outcomes', 'Patient Reported Outcomes', 'Patient Reported Outcomes', 'PIVOT app Assessment', 'Functional hop series', 'Functional hop series', 'Functional hop series', 'Drop vertical jump', 'Drop vertical jump', 'Strength Testing', 'Strength Testing', 'Strength Testing', 'Standing Flexion Radiograph', 'PIVOT App Assessment', 'PIVOT App Assessment', 'PIVOT App Assessment', '18']\n\n###\n\n", "completion": "END"}